Selected article for: "low number and lung evaluation"

Author: Nazerian, Peiman; Morello, Fulvio; Prota, Alessio; Betti, Laura; Lupia, Enrico; Apruzzese, Luc; Oddi, Matteo; Grosso, Federico; Grifoni, Stefano; Pivetta, Emanuele
Title: Diagnostic accuracy of physician’s gestalt in suspected COVID‐19: Prospective bicentric study
  • Cord-id: zglimqrs
  • Document date: 2021_3_15
  • ID: zglimqrs
    Snippet: OBJECTIVES: Physicians’ gestalt is central in the diagnostic pipeline of suspected COVID‐19, due to the absence of a single tool allowing conclusive rule in or rule out. The aim of this study was to estimate the diagnostic test characteristics of physician's gestalt for COVID‐19 in the emergency department (ED), based on clinical findings or on a combination of clinical findings and bedside imaging results. METHODS: From April 1 to April 30, 2020, patients with suspected COVID‐19 were pr
    Document: OBJECTIVES: Physicians’ gestalt is central in the diagnostic pipeline of suspected COVID‐19, due to the absence of a single tool allowing conclusive rule in or rule out. The aim of this study was to estimate the diagnostic test characteristics of physician's gestalt for COVID‐19 in the emergency department (ED), based on clinical findings or on a combination of clinical findings and bedside imaging results. METHODS: From April 1 to April 30, 2020, patients with suspected COVID‐19 were prospectively enrolled in two EDs. Physicians prospectively dichotomized patients in COVID‐19 likely or unlikely twice: after medical evaluation of clinical features (clinical gestalt [CG]) and after evaluation of clinical features and results of lung ultrasound or chest x‐ray (clinical and bedside imaging–integrated gestalt [CBIIG]). The final diagnosis was adjudicated after independent review of 30‐day follow‐up data. RESULTS: Among 838 ED enrolled patients, 193 (23%) were finally diagnosed with COVID‐19. The area under the curve (AUC), sensitivity, and specificity of CG and CBIIG for COVID‐19 were 80.8% and 91.6% (p < 0.01), 82.9% and 91.4% (p = 0.01), and 78.6% and 91.8% (p < 0.01), respectively. CBIIG had similar AUC and sensitivity to reverse transcription–polymerase chain reaction (RT‐PCR) for SARS‐CoV‐2 on the first nasopharyngeal swab per se (93.5%, p = 0.24; and 87%, p = 0.17, respectively). CBIIG plus RT‐PCR had a sensitivity of 98.4% for COVID‐19 (p < 0.01 vs. RT‐PCR alone) compared to 95.9% for CG plus RT‐PCR (p = 0.05). CONCLUSIONS: In suspected COVID‐19, CG and CBIIG have fair diagnostic accuracy, in line with physicians’ gestalt for other acute conditions. Negative RT‐PCR plus low probability based on CBIIG can rule out COVID‐19 with a relatively low number of false‐negative cases.

    Search related documents:
    Co phrase search for related documents
    • accurate estimate and low prevalence: 1
    • acute respiratory syndrome and additional oxygen: 1, 2, 3, 4, 5
    • acute respiratory syndrome and local facility: 1, 2, 3
    • acute respiratory syndrome and local protocol: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory syndrome and low prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung ultrasound: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lus examination: 1, 2, 3, 4
    • acute respiratory syndrome and lus lung ultrasound: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lus perform: 1
    • local facility and lung disease: 1
    • local protocol and lung disease: 1
    • local protocol and lung ultrasound: 1, 2
    • local protocol and lus lung ultrasound: 1
    • low prevalence and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • low prevalence and lung ultrasound: 1
    • low prevalence and lus lung ultrasound: 1
    • lung disease and lus examination: 1, 2, 3, 4, 5, 6
    • lung disease and lus lung ultrasound: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25